Australia has proposed amendments to the Narcotic Drugs Act that would overhaul the medical marijuana industry by streamlining the licensing process for businesses and assure access for patients. Rhys Cohen, editor-at-large for the Australian publication Cannabiz, said the measures will allow companies to operate more efficiently and flexibly if fully implemented. “For foreign businesses, it reduces the cost and risk of setting up Australian-based licensed operations. And globally, once these changes are implemented and refined, it means Australian exports will be even more competitive,” he told Marijuana Business Daily. The Narcotic Drugs Amendment Bill 2021 was introduced in the House of Representatives last week where it awaits the first vote. The proposed amendments would implement some of the key recommendations outlined in the McMillan Review of the country’s medical cannabis industry in 2019.

Marijuana Business Daily, 02/08/2021 08:59:00

Open article: